Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery
Primary Purpose
Breast Cancer
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Armeo®Power
Conventional rehabilitation protocol
Sponsored by
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring Breast cancer, Rehabilitation, Robotics
Eligibility Criteria
Inclusion Criteria:
- Women submitted to quadrantectomy, simple mastectomy, radical mastectomy or modified radical mastectomy with complete axillary dissection.
- Women from 30 to 60 years old.
- Postoperatory range from 20 to 80 days.
Exclusion Criteria:
- Bilateral surgery
- Radiotherapy treatment in progress
- Upper limb metastasis
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Armeo
Conventional
Arm Description
Patients group (54 patients) for robotic therapy.
Patients group (54 patients) for conventional rehabilitation protocol.
Outcomes
Primary Outcome Measures
Pain classification change
Pain measure will be done through Shoulder Pain and Disability Index (SPADI) questionnaire, classifying it from 0 (low) to 100 (high).
Arm strength change
Arm strength measure will be performed with a hand dynamometer.
Change in the amplitude of arm movement
The amplitude of arm movement wil be measured by a goniometer.
Upper limb disability change
This outcome wil be measured by Disability of the Arm, Shoulder and Hand (DASH) questionnaire, classifying it from 0 (low) to 100 (high).
Secondary Outcome Measures
Quality of life change
Quality of life will be assessed by Functional Assessment of Cancer Therapy-Breast (FACT B+4) questionnaire.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04025112
Brief Title
Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery
Official Title
Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional in Postoperative Period of Patients Submitted to Surgical Treatment of Breast Cancer
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
July 20, 2019 (Anticipated)
Primary Completion Date
July 30, 2020 (Anticipated)
Study Completion Date
December 20, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Barretos Cancer Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the effects of rehabilitation robotics in upper limb functionality involved in the surgical treatment of breast cancer. The study will be conducted following the delineation of randomized clinical trial. It will be assessed 108 women aged between 30 and 60 years, submitted to surgical treatment of breast cancer and axillary dissection.
Detailed Description
Breast cancer is one of the most common neoplasia types, with greater involvement in the female population, showing a high mortality rate in Brazil, due to diagnosis in advanced stages. With the increased survival of women treated for breast cancer, the evaluation of the effect of therapeutic resources for the morbidities resulting from surgical treatment of breast cancer are essential. The aim of this study is to evaluate the effects of rehabilitation robotics in upper limb functionality involved in the surgical treatment of breast cancer. The study will be conducted following the delineation of randomized clinical trial. It will be assessed 108 women aged between 30 and 60 years submitted to surgical treatment of breast cancer and axillary dissection, divided between two equal groups: control group (GC) - composed of women who had undergone conventional rehabilitation and experimental group (GE) - composed of women who had undergone rehabilitation robotics. The data obtained in the study aim to improve the forms of intervention against the functional alterations resulting from surgical treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
Breast cancer, Rehabilitation, Robotics
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
108 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Armeo
Arm Type
Experimental
Arm Description
Patients group (54 patients) for robotic therapy.
Arm Title
Conventional
Arm Type
Active Comparator
Arm Description
Patients group (54 patients) for conventional rehabilitation protocol.
Intervention Type
Device
Intervention Name(s)
Armeo®Power
Intervention Description
Randomized patients will be offered rehabilitation robotic using Armeo®Power from Hocoma, the first robotic arm exoskeleton for integrated arm and hand therapy, during one month, three times a week, totalizing 12 sessions of 45 minutes.
Intervention Type
Other
Intervention Name(s)
Conventional rehabilitation protocol
Intervention Description
Randomized patients will be offered the conventional rehabilitation protocol from Barretos Cancer Hospital during one month, three times a week, totalizing 12 sessions of 45 minutes.
Primary Outcome Measure Information:
Title
Pain classification change
Description
Pain measure will be done through Shoulder Pain and Disability Index (SPADI) questionnaire, classifying it from 0 (low) to 100 (high).
Time Frame
"15 days" and "30 days"
Title
Arm strength change
Description
Arm strength measure will be performed with a hand dynamometer.
Time Frame
"15 days" and "30 days"
Title
Change in the amplitude of arm movement
Description
The amplitude of arm movement wil be measured by a goniometer.
Time Frame
"15 days" and "30 days"
Title
Upper limb disability change
Description
This outcome wil be measured by Disability of the Arm, Shoulder and Hand (DASH) questionnaire, classifying it from 0 (low) to 100 (high).
Time Frame
"15 days" and "30 days"
Secondary Outcome Measure Information:
Title
Quality of life change
Description
Quality of life will be assessed by Functional Assessment of Cancer Therapy-Breast (FACT B+4) questionnaire.
Time Frame
"15 days" and "30 days"
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Breast cancer in women
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women submitted to quadrantectomy, simple mastectomy, radical mastectomy or modified radical mastectomy with complete axillary dissection.
Women from 30 to 60 years old.
Postoperatory range from 20 to 80 days.
Exclusion Criteria:
Bilateral surgery
Radiotherapy treatment in progress
Upper limb metastasis
12. IPD Sharing Statement
Learn more about this trial
Randomized Clinical Trial Comparing Rehabilitation Robotic Versus Conventional After Breast Cancer Surgery
We'll reach out to this number within 24 hrs